Tell-tale gene Neuregulin 3 affects success of drug used to treat chronic pain: Women who carry this particular form of a pain gene are more likely to respond well to a common medication used to treat long-term discomfort, research shows. In a study, women with chronic pelvic pain who had a naturally occurring variation of a gene, known as Neuregulin 3, in their DNA were more likely to experience relief after taking the painkilling drug gabapentin. Targeting gabapentin use to those with this genetic marker would avoid ineffective treatment and unwanted side-effects in those who are unlikely to respond, experts
Tell-tale gene Neuregulin 3 affects success chronic pain treatment as seen on The Hippocratic Post.